0001209191-18-022004.txt : 20180328 0001209191-18-022004.hdr.sgml : 20180328 20180328211226 ACCESSION NUMBER: 0001209191-18-022004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180326 FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRASAD SUYASH CENTRAL INDEX KEY: 0001679129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 18720349 MAIL ADDRESS: STREET 1: C/O AUDENTES THERAPEUTICS, INC. STREET 2: 101 MONTGOMERY ST., SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-26 0 0001628738 Audentes Therapeutics, Inc. BOLD 0001679129 PRASAD SUYASH C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO CA 94108 0 1 0 0 Senior VP & Chief Med Officer Common Stock 2018-03-26 4 M 0 1900 0.79 A 1900 D Common Stock 2018-03-26 4 S 0 1900 30.00 D 0 D Common Stock 2018-03-27 4 M 0 300 0.79 A 300 D Common Stock 2017-03-27 4 S 0 300 30.00 D 0 D Stock Option (right to buy) 0.79 2018-03-26 4 M 0 1900 0.00 D 2024-02-18 Common Stock 1900 78970 D Stock Option (right to buy) 0.79 2018-03-27 4 M 0 300 0.00 D 2024-02-18 Common Stock 300 78670 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The option vested as to 25% of the total shares on February 18, 2015, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on February 18, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Thomas Soloway as attorney-in-fact for Suyash Prasad 2018-03-28